# Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome

> **NCT06807164** · PHASE2 · RECRUITING · sponsor: **Centre Oscar Lambret** · enrollment: 123 (estimated)

## Conditions studied

- Post-Mastectomy Neuropathic Pain Syndrome

## Interventions

- **DRUG:** Capsaicin 8% Patch
- **PROCEDURE:** Serratus Plane Block
- **PROCEDURE:** Botulinum Toxin A

## Key facts

- **NCT ID:** NCT06807164
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2027-08-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 123 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06807164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06807164, "Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06807164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*